The U.S. Food and Drug Administration on Thursday advised doctors to stop using power morcellators in women’s abdomens to remove uterine growths called fibroids, citing the risk of spreading cancer.
BY ANDREW POLLACK, THE NEW YORK TIMES MARCH 12, 2014 The Pap test, a ritual for women that has been the mainstay of cervical cancer prevention for 60 years, may be about to play a less crucial role. A federal advisory committee recommended unanimously on Wednesday that a DNA test developed by Roche be approved for […]
the FDA has already made a decision that could potentially harm thousands of patients. The agency just approved a new diabetes medication that doesn’t noticeably improve health but may in fact cause cancer.
Modern Healthcare, January 22, 2014. “With new drugs, there is often an exaggeration of the benefits and underreporting of the risks,” said Diana Zuckerman, president of the National Research Center for Women & Families, who has testified at several hearings on drug safety. “There’s so much emphasis on drugs being the latest, the most innovative and novel—but unfortunately this usually means it’s just new, not necessarily better.”
Huffington Post. October 2, 2013. What the government shutdown and Obamacare really all about?
New York Times. September 9, 2013. It is fairly well known that reports made to the F.D.A. represent only “the tip of the iceberg” of surgical complications and adverse drug reactions, said Diana Zuckerman, the president of the National Research Center for Women and Families and an expert on the safety of medical devices.